catalyst

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2010-07 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. — primary completion
Type
Trial Readout
Date
2010-07
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
trial